(Q44621243)

English

Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

5

object named as

Satoshi Kurisu

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Masaharu Ishihara

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Ichiro Inoue

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Takuji Kawagoe

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yuji Shimatani

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Kenji Nishioka

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Takashi Umemura

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Shuji Nakamura

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Masashi Yoshida

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0002870303001674?httpAccept=text/xml

1 reference

10.1016/S0002-8703(03)00167-4

https://api.crossref.org/works/10.1016/S0002-8703(03)00167-4

22 March 2024

https://api.elsevier.com/content/article/PII:S0002870303001674?httpAccept=text/plain

1 reference

10.1016/S0002-8703(03)00167-4

https://api.crossref.org/works/10.1016/S0002-8703(03)00167-4

22 March 2024

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

146

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

674-678

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Hyperglycemia during acute myocardial infarction. A six-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

"Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

The diabetic heart is more sensitive to ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Adaptation and maladaptation of the heart in diabetes: Part I: general concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900167-4

7 January 2021

Identifiers

10.1016/S0002-8703(03)00167-4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44621243&oldid=2108415687"